The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Fluoxetine (Prozac) interaction with the mitochondrial voltage‐dependent anion channel and protection against apoptotic cell death
Abstract
Here, we demonstrate that fluoxetine interacted with VDAC and decreased its conductance. Fluoxetine inhibited the opening of the mitochondrial permeability transition pore, the release of cytochrome c, and protected against staurosporine‐induced apoptotic cell death. These findings may explain some of the reported fluoxetine side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nahon et al. (2005) demonstrated that fluoxetine was able to inhibit the opening of the mitochondrial permeability transition (MPT) pore, the release of cytochrome c (cytC) and protected against staurosporine-induced apoptotic cell death [8].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [8]
Citations
Cites
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432
The mitochondrial permeability transition
Zoratti, M., & Szabó, I. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00003-a · Cited by 2,410
Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 643
VDAC: The channel at the interface between mitochondria and the cytosol
Colombini, M. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000009862.17396.8d · Cited by 500
AZOULAY-ZOHAR, H., ISRAELSON, A., ABU-HAMAD, S., & SHOSHAN-BARMATZ, V. (2004) · Biochemical Journal · doi:10.1042/bj20031465 · Cited by 408
Self-citationGINCEL, D., ZAID, H., & SHOSHAN-BARMATZ, V. (2001) · Biochemical Journal · doi:10.1042/bj3580147 · Cited by 396 · cited 6×
“However, these effects of fluoxetine on mitochondrial activities may result from interacting with VDAC and decreasing its conductance as a channel providing passage for Ca [19],”
BackgroundMethodInfluentialSelf-citationEssential Role of Voltage-Dependent Anion Channel in Various Forms of Apoptosis in Mammalian Cells
Shimizu, S., Matsuoka, Y., Shinohara, Y., Yoneda, Y., & Tsujimoto, Y. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.2.237 · Cited by 368
Rostovtseva, T. K., & Colombini, M. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78841-6 · Cited by 360
Inhibition of Neuronal Na+ Channels by Antidepressant Drugs
Pancrazio, J. J., Kamatchi, G. L., Roscoe, A. K., & Lynch, C. I. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37206-4 · Cited by 309
Cited by
Sorted by citations
VDAC, a multi-functional mitochondrial protein regulating cell life and death
Shoshan‐Barmatz, V., Pinto, V. D., Zweckstetter, M., Raviv, Z., Keinan, N., & Arbel, N. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.03.002 · Cited by 824
Self-citationThe mitochondrial permeability transition from in vitro artifact to disease target
Bernardi, P., Krauskopf, A., Basso, E., Petronilli, V., Blalchy‐Dyson, E., Di Lisa, F., & Forte, M. A. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05213.x · Cited by 627
Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 341
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
VDAC, a multi-functional mitochondrial protein as a pharmacological target
Shoshan‐Barmatz, V., & Ben-Hail, D. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.04.001 · Cited by 257
Self-citationBehr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205
Shu, X., Sun, Y., Sun, X., Zhou, Y., Bian, Y., Shu, Z., Ding, J., Lu, M., & Hu, G. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1813-9 · Cited by 203
VDAC1: from structure to cancer therapy
Shoshan‐Barmatz, V., & Mizrachi, D. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00164 · Cited by 200
Self-citationVDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis
Magrì, A., Reina, S., & Pinto, V. D. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00108 · Cited by 186
A mitochondrial bioenergetic basis of depression
Klinedinst, N. J., & Regenold, W. T. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9584-6 · Cited by 161
Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Shoshan‐Barmatz, V., & Golan, M. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712798992110 · Cited by 142
Self-citationMcKernan, D. P., Dinan, T. G., & Cryan, J. F. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.006 · Cited by 139
Nanotechnology inspired tools for mitochondrial dysfunction related diseases
Wen, R. M., Banik, B., Pathak, R., Kumar, A., Kolishetti, N., & Dhar, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.024 · Cited by 130
Wang, Y., Neumann, M., Hansen, K., Hong, S. M., Kim, S. H., Noble‐Haeusslein, L. J., & Liu, J. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1648 · Cited by 107
Therapeutic Potential of Fluoxetine in Neurological Disorders
Mostert, J. P., Koch, M. W., Heerings, M. A. P., Heersema, D. J., & Keyser, J. D. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2008.00040.x · Cited by 102
Chiou, S., Chen, S., Peng, C., Chang, Y.-L., Ku, H., Hsu, W., Ho, L. L.-T., & Lee, C.-H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.180 · Cited by 96
Inflammation and Depression: Why Poststroke Depression may be the Norm and Not the Exception
Pascoe, M. C., Crewther, S. G., Carey, L. M., & Crewther, D. P. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00565.x · Cited by 95
Fluoxetine and the mitochondria: A review of the toxicological aspects
de Oliveira, M. R. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.07.001 · Cited by 96
Drzyzga, Ł. R., Marcinowska, A., & Obuchowicz, E. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.03.009 · Cited by 90
In vitro inhibition of mitochondrial respiratory rate by antidepressants
Hroudová, J., & Fišar, Z. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.017 · Cited by 85
Yue, J. K., Burke, J., Upadhyayula, P. S., Winkler, E. A., Deng, H., Robinson, C. K., Pirracchio, R., Suen, C. G., Sharma, S., Ferguson, A. R., et al. (2017) · Brain Sciences · doi:10.3390/brainsci7080093 · Cited by 78
Wann, B. P., Bah, T. M., Kaloustian, S., Boucher, M., Dufort, A., Marec, N. L., Godbout, R., & Rousseau, G. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089820 · Cited by 71
Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 73
A Role for Voltage-Dependent Anion Channel Vdac1 in Polyglutamine-Mediated Neuronal Cell Death
Ghosh, T., Pandey, N., Maitra, A., Brahmachari, S. K., & Pillai, B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001170 · Cited by 64
Sonei, N., Amiri, S., Jafarian, I., Anoush, M., Rahimi-Balaei, M., Bergen, H., Haj‐Mirzaian, A., & Hosseini, M. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1149218 · Cited by 59
Wann, B. P., Bah, T. M., Boucher, M., Courtemanche, J., Marec, N. L., Rousseau, G., & Godbout, R. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0702 · Cited by 59
Kushwah, N., Jain, V., Deep, S., Prasad, D. N., Singh, S. B., & Khan, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149309 · Cited by 60
RetractedIzadyar, A., Arachchige, D. R., Cornwell, H., & Hershberger, J. C. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.09.048 · Cited by 58
Pharmacological modulation of mitochondrial ion channels
Leanza, L., Checchetto, V., Biasutto, L., Rossa, A., Costa, R., Bachmann, M., Zoratti, M., & Szabó, I. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14544 · Cited by 50
Mechanisms of antidepressant action: An integrated dopaminergic perspective
Porcelli, S., Drago, A., Fabbri, C., & Serretti, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.005 · Cited by 53
Huang, W. C., Zhao, Y. C., Zhu, X., Cai, Z., Wang, S., Yao, S., Qi, Z., & Xie, P. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9822-5 · Cited by 47
Perić, I., Costina, V., Stanisavljević, A., Findeisen, P., & Filipović, D. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.034 · Cited by 46
Filipović, D., Costina, V., Perić, I., Stanisavljević, A., & Findeisen, P. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.025 · Cited by 46
Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 42
Self-citationNeuroprotective Effect of Apigenin on Depressive-Like Behavior: Mechanistic Approach
Bijani, S., Dizaji, R., Sharafi, A., & Hosseini, M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03473-0 · Cited by 42
Benek, O., Aitken, L., Hroch, L., Kuča, K., Gunn‐Moore, F. J., & Musílek, K. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150114163051 · Cited by 41
Fluorometric study of fluoxetine DNA binding
Kashanian, S., Javanmardi, S., Chitsazan, A., Paknejad, M., & Omidfar, K. (2012) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2012.04.002 · Cited by 40
Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome
Zhang, C., Wu, Z., Hong, W., Wang, Z., Peng, D., Chen, J., Yuan, C., Yu, S., Xu, L., & Fang, Y. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.010 · Cited by 38
Chilmończyk, Z., Bojarski, A. J., Pilc, A., & Sylte, I. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.011 · Cited by 31
Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection
Steiner, J. P., Bachani, M., Wolfson-Stofko, B., Lee, M., Wang, T., Li, G., Li, W., Strayer, D. S., Haughey, N. J., & Nath, A. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0315-9 · Cited by 30
New Perspectives for the Rescue of Cognitive Disability in Down Syndrome
Bartesaghi, R., Haydar, T. F., Delabar, J. M., Dierssen, M., Martínez‐Cué, C., & Bianchi, D. W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2775-15.2015 · Cited by 32
Abdelrahman, S. A., Samak, M. A., & Shalaby, S. M. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2838-6 · Cited by 28
Jantas, D., Krawczyk, S., & Lasoń, W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9430-3 · Cited by 29
Effects of fluoxetine on plasticity and apoptosis evoked by chronic stress in rat prefrontal cortex
Djordjevic, A. D., Djordjevic, J., Elaković, I., Adžić, M., Matić, G. M., & Radojcic, M. B. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.07.042 · Cited by 27
Targeting Mitochondrial Ion Channels to Fight Cancer
Bachmann, M., Costa, R., Peruzzo, R., Prosdocimi, E., Checchetto, V., & Leanza, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072060 · Cited by 28
Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders?
Ben‐Shachar, D., & Ene, H. M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.007 · Cited by 27
The Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity
Morén, C., Juárez‐Flores, D. L., Cardellach, F., & Garrabou, G. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160322143631 · Cited by 25
Mazure, N. M. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00193 · Cited by 25
Protective effects of melatonin on long-term administration of fluoxetine in rats
Khaksar, M., Oryan, A., Sayyari, M., Rezabakhsh, A., & Rahbarghazi, R. (2017) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2017.05.002 · Cited by 25
Elmorsy, E. M., Al-Ghafari, A. B., Helaly, A. M., Hisab, A. S., Oehrle, B., & Smith, P. A. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx090 · Cited by 24
The neurodegenerative hypothesis of depression and the influence of antidepressant medications
Hall, S., Parr, B.-A., Hussey, S., Anoopkumar‐Dukie, S., Arora, D. S., & Grant, G. D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176967 · Cited by 26
Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications
Lauterbach, E. C., Shillcutt, S. D., Victoroff, J., Coburn, K. L., & Mendez, M. F. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.2.130 · Cited by 22
Sołek, P., Mytych, J., Tabęcka-Łonczyńska, A., & Koziorowski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111855 · Cited by 21
Marchi, U. D., Fernandez‐Martinez, S., de la Fuente, S., Wiederkehr, A., & Domingo, J. S. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15018 · Cited by 22
Approaching the structure of human VDAC1, a key molecule in mitochondrial cross-talk
Zeth, K., Meins, T., & Vonrhein, C. (2008) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-008-9144-z · Cited by 19
Reisi, P., Zarei, G., Alaei, H., & Javanmard, S. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.142044 · Cited by 18
Silva, T. L. A., Braz, G. R. F., Silva, S. C. D. A., Pedroza, A. A. D. S., Freitas, C. D. M., Ferreira, D. J. S., da Silva, A. I., & Lagranha, C. J. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13971 · Cited by 17
Nguyen, T. M. D., Klett, D., Filliatreau, L., & Combarnous, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217519 · Cited by 16
Choi, K. H., Le, T., McGuire, J. L., Coyner, J. L., Higgs, B. W., Diglisic, S., Johnson, L. R., Benedek, D. M., & Ursano, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049183 · Cited by 15
Chang, E.-A., Beyhan, Z., Yoo, M.-S., Siripattarapravat, K., Ko, T., Lookingland, K. J., Madhukar, B. V., & Cibelli, J. B. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092851ec · Cited by 15
New findings concerning vertebrate porin II — On the relevance of glycine motifs of type-1 VDAC
THINNES, F. P. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.01.008 · Cited by 14
Quinidine partially blocks mitochondrial voltage-dependent anion channel (VDAC)
Malik, C., & Ghosh, S. (2020) · European Biophysics Journal · doi:10.1007/s00249-020-01426-z · Cited by 14
Intracellular Calcium Homeostasis and Kidney Disease
Song, N., Yang, M., Zhang, H., & Yang, S. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666201102114257 · Cited by 14
Effects of fluoxetine on cloned Kv4.3 potassium channels
Jeong, I., Choi, J., & Hahn, S. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.028 · Cited by 14
Gorny, H., Mularoni, A., Delcros, J., Freton, C., Preto, J., & Krimm, I. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2121821 · Cited by 15
Murai, M., Okuda, A., Yamamoto, T., Shinohara, Y., & Miyoshi, H. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01011 · Cited by 15
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
Bockstaele, E. J. V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6 · Cited by 14
Nahas, Z. H., JIANG, Y., Zeidan, Y. H., Bielawska, A. E., Szulc, Z. M., DeVane, L., Kalivas, P. W., & Hannun, Y. A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.07.040 · Cited by 12
Small-Molecule Modulators of Mitochondrial Channels as Chemotherapeutic Agents
Parrasia, S., Mattarei, A., Furlan, A., Zoratti, M., & Biasutto, L. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000192 · Cited by 12
Enantiomeric separation of antidepressant drug fluoxetine based on chiral membranes
Salgın, S., Salgın, U., & Tuzlalı, N. (2018) · Desalination and Water Treatment · doi:10.5004/dwt.2018.22130 · Cited by 12
Shin, E., Jeong, J. H., Nguyen, B.-T., Sharma, N., Nah, S.-Y., Chung, Y. H., Lee, Y., Byun, J. K., Nabeshima, T., Ko, S. K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137219 · Cited by 11
Rayan, N. A., Aow, J., Lim, M. G. L., Arcego, D. M., Ryan, R., Nourbakhsh, N., de Lima, R. M. S., Craig, K., Zhang, T., Goh, Y. T., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02619-0 · Cited by 10
Post-Myocardial Infarction Depression
Rousseau, G., Bah, T. M., & Godbout, R. (2012) · InTech eBooks · doi:10.5772/33408 · Cited by 10
Karuppagounder, V., Pinamont, W. J., Yoshioka, N. K., Elbarbary, R. A., & Kamal, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147933 · Cited by 8
Hwang, S., & Kim, J.-K. (2020) · Chonnam Medical Journal · doi:10.4068/cmj.2020.56.1.20 · Cited by 8
Malik, C., & Ghosh, S. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00134-1 · Cited by 8
Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells
Wang, Y., Hilton, B., Cui, K., & Zhu, M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9534-z · Cited by 8
The Rhizome of Trillium tschonoskii Maxim. Extract Induces Apoptosis in Human Lung Cancer Cells
Huang, W., Zou, K., & Xiong, B. (2011) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2011-9-1007 · Cited by 7
Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers
Fišar, Z. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_6 · Cited by 7
Lopresti, A. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00015-9 · Cited by 6
Colorimetric recognition of fluoxetine and sertraline using citrate-capped gold nanoparticles
Laghari, S., & Khuhawar, M. Y. (2023) · Chemical Papers · doi:10.1007/s11696-023-02990-2 · Cited by 5
Nguyen, T. M. D., Klett, D., & Combarnous, Y. (2021) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2021.25.3.189 · Cited by 5
Dopaminergic system: stress, depression, cancer (part 1)
Bocharova, O. A., Бочаров, Е. В., Kucheryanu, V. G., & Карпова, Р. В. (2019) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2019-18-3-6-14 · Cited by 3
Xu, H., Ding, Y., Qi, X., Zhang, Z., & Su, J. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00428 · Cited by 2
Ho, T. H., Tran, K. G., Huynh, L. K., & Nguyen, T. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c04631 · Cited by 1
Depression: Current Conceptual Trends
Nahas, Z. H. (2016) · Springer eBooks · doi:10.1007/978-1-59745-495-7_1 · Cited by 1
Shen, L. (2006) · University Library - University of Saskatchewan (University of Saskatchewan)
Shoshan‐Barmatz, V., Shteinfer‐Kuzmine, A., Ben-Hail, D., Arif, T., & Mizrachi, D. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_16
Self-citationDrug‐Induced Mitochondrial Toxicity during Pregnancy
Juárez‐Flores, D. L., Hernández, A. S., García‐Otero, L., Guitart‐Mampel, M., Catalán‐García, M., González‐Casacuberta, I., Milisenda, J. C., Grau, J. M., Cardellach, F., Morén, C., et al. (2018) · doi:10.1002/9781119329725.ch33
Functional facets of dopaminergic system and cancer. Part 1
Bocharov, E. V., Кучеряну, В. Г., & Bocharova, O. A. (2017) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2017.03.116-126
Nguyen, T. M. D., Hằng, N. T., Minh, N. L. C., Sơn, T. T., & Dương, N. T. (2020) · Vietnam Journal of Biotechnology · doi:10.15625/1811-4989/17/4/14743
(2005) · FEBS Letters · doi:10.1016/s0014-5793(05)01501-2
Karuppagounder, V., Pinamont, W. J., Yoshioka, N. K., Elbarbary, R. A., & Kamal, F. (2022) · doi:10.22541/au.164873432.28611937/v1
Nguyen, T. M. D., & Nguyen, T. M. D. (2022) · Veterinary Integrative Sciences · doi:10.12982/vis.2022.056
Salimi, A., Khezri, S., Azami, A. M., Ayremlou, S. T., & Adhami, V. (2025) · Xenobiotica · doi:10.1080/00498254.2025.2564120
Gordon, S. (2012) · University of Brighton Repository (University of Brighton)
Pajović, S. B., & Filipović, D. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0152
Lu, L., Pan, C., Fu, L., Zhao, L., Wang, H.-Y., Yao, W., & Yang, M. (2026) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2026.110551
Metadata
- Authors
- Nahon, E., Israelson, A., Abu-Hamad, S., & Shoshan-Barmatz, V.
- Affiliations
- Ben-Gurion University of the Negev (IL)
- ORCID
- Israelson, Adrian
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2005-08-24
- Volume
- 579
- Issue
- 22
- Pages
- 5105-5110
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W1983099105
- Cited by
- 101
- References
- 34
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 11
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- fluoxetine, mitochondrial voltage-dependent anion channel, voltage-dependent anion channel, mitochondrial permeability transition pore, cytochrome c release, staurosporine-induced apoptosis, apoptosis, adverse drug reactions, serotonin reuptake inhibition
- MeSH terms
- Animals, Cell Line, Enzyme Inhibitors, Fluoxetine, Humans, Mitochondria, Liver, Apoptosis, Selective Serotonin Reuptake Inhibitors, Porins, Staurosporine, Cytochromes c, Voltage-Dependent Anion Channels, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review